Wuhan Hiteck Biological Pharma Co Ltd (300683) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.008x

Based on the latest financial reports, Wuhan Hiteck Biological Pharma Co Ltd (300683) has a cash flow conversion efficiency ratio of -0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-17.49 Million ≈ $-2.56 Million USD) by net assets (CN¥2.24 Billion ≈ $328.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300683 company net worth for the company's overall valuation and market capitalisation.

Wuhan Hiteck Biological Pharma Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Wuhan Hiteck Biological Pharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Wuhan Hiteck Biological Pharma Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wuhan Hiteck Biological Pharma Co Ltd ranked by their cash flow conversion efficiency. Explore Wuhan Hiteck Biological Pharma Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
WIA Gold Ltd AU:WIA	0.000x
Changzhou Xiangming Intelligent Drive System Corporation SHE:301226	N/A
Tengda Construction Group Co Ltd SHG:600512	-0.002x
Beijing Jingpin Tezhuang Technology Co. Ltd. A SHG:688084	N/A
Carter Bank and Trust NASDAQ:CARE	0.028x
Sichuan Troy Information Technology Co Ltd SHE:300366	-0.022x
CHC Resources Corp TW:9930	0.081x
Taiwan Shin Kong Security Co Ltd TW:9925	0.008x

Annual Cash Flow Conversion Efficiency for Wuhan Hiteck Biological Pharma Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Wuhan Hiteck Biological Pharma Co Ltd from 2013 to 2025. View Wuhan Hiteck Biological Pharma Co Ltd (300683) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.17 Billion ≈ $317.45 Million	CN¥-76.54 Million ≈ $-11.20 Million	-0.035x	-475.05%
2024-12-31	CN¥2.41 Billion ≈ $352.89 Million	CN¥22.69 Million ≈ $3.32 Million	0.009x	+341.74%
2023-12-31	CN¥2.50 Billion ≈ $365.17 Million	CN¥5.31 Million ≈ $777.64K	0.002x	-90.62%
2022-12-31	CN¥2.34 Billion ≈ $341.71 Million	CN¥53.03 Million ≈ $7.76 Million	0.023x	+340.20%
2021-12-31	CN¥2.34 Billion ≈ $342.86 Million	CN¥12.09 Million ≈ $1.77 Million	0.005x	+145.17%
2020-12-31	CN¥1.72 Billion ≈ $252.41 Million	CN¥-19.70 Million ≈ $-2.88 Million	-0.011x	-131.90%
2019-12-31	CN¥1.76 Billion ≈ $257.61 Million	CN¥63.03 Million ≈ $9.22 Million	0.036x	-16.64%
2018-12-31	CN¥1.71 Billion ≈ $250.17 Million	CN¥73.42 Million ≈ $10.74 Million	0.043x	-15.06%
2017-12-31	CN¥1.64 Billion ≈ $240.44 Million	CN¥83.08 Million ≈ $12.16 Million	0.051x	-75.28%
2016-12-31	CN¥703.35 Million ≈ $102.92 Million	CN¥143.86 Million ≈ $21.05 Million	0.205x	-23.66%
2015-12-31	CN¥596.76 Million ≈ $87.32 Million	CN¥159.89 Million ≈ $23.40 Million	0.268x	+6.18%
2014-12-31	CN¥536.59 Million ≈ $78.52 Million	CN¥135.40 Million ≈ $19.81 Million	0.252x	-16.35%
2013-12-31	CN¥254.64 Million ≈ $37.26 Million	CN¥76.82 Million ≈ $11.24 Million	0.302x	--

About Wuhan Hiteck Biological Pharma Co Ltd

SHE:300683 China Drug Manufacturers - Specialty & Generic

Market Cap

$480.19 Million

CN¥3.28 Billion CNY

Market Cap Rank

#12564 Global

#3683 in China

Share Price

CN¥25.07

Change (1 day)

+2.58%

52-Week Range

CN¥22.76 - CN¥48.78

All Time High

CN¥84.19